Amalgamated Bank cut its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 8.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,703 shares of the semiconductor company’s stock after selling 2,873 shares during the period. Amalgamated Bank’s holdings in Synopsys were worth $15,387,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in the business. Parnassus Investments LLC acquired a new position in Synopsys in the third quarter valued at approximately $633,469,000. Edgewood Management LLC increased its holdings in Synopsys by 18.9% in the third quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock valued at $1,554,540,000 after buying an additional 487,025 shares in the last quarter. Van ECK Associates Corp increased its holdings in Synopsys by 26.5% in the third quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock valued at $791,923,000 after buying an additional 335,993 shares in the last quarter. Impax Asset Management Group plc raised its position in shares of Synopsys by 120.2% in the third quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company’s stock worth $248,497,000 after acquiring an additional 267,836 shares during the period. Finally, Wellington Management Group LLP increased its stake in shares of Synopsys by 32.5% in the 3rd quarter. Wellington Management Group LLP now owns 1,048,709 shares of the semiconductor company’s stock valued at $531,056,000 after purchasing an additional 257,526 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.66% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on SNPS
Synopsys Trading Down 2.6 %
NASDAQ:SNPS opened at $457.95 on Wednesday. Synopsys, Inc. has a twelve month low of $457.00 and a twelve month high of $624.80. The company has a market cap of $70.79 billion, a P/E ratio of 31.54, a P/E/G ratio of 3.23 and a beta of 1.12. The company’s 50-day moving average price is $508.09 and its 200-day moving average price is $516.89.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- 3 Healthcare Dividend Stocks to Buy
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- What Are Dividend Contenders? Investing in Dividend Contenders
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.